Can Mazdutide Cause Weight Gain?

What Mazdutide Is and How It Works

Mazdutide is a dual GLP-1 and glucagon receptor agonist developed primarily for obesity and type 2 diabetes management. Understanding how it works is essential before answering whether it can cause weight gain, because the mechanism points strongly in the opposite direction.

Unlike single-receptor GLP-1 medications, mazdutide activates both the GLP-1 pathway, which reduces appetite and slows gastric emptying, and the glucagon receptor pathway, which increases energy expenditure. This combination creates a compounding effect: you consume fewer calories while your body burns more of them. Clinical trials, conducted primarily in China across phase 2 and phase 3 stages, confirmed significant body weight reductions at multiple dose levels, firmly establishing mazdutide as a weight loss agent rather than a metabolic disruptor.

Does Mazdutide Directly Cause Weight Gain as a Side Effect?

The short answer is no. No clinical evidence from mazdutide trials identifies weight gain as a direct side effect during active treatment. Participants across dose groups experienced reductions in body weight, with higher doses generally producing greater losses, a pattern described as dose-dependent weight loss.

Some GLP-1 class drugs can be associated with minor fluid shifts or changes in muscle composition, but these have not been documented as net weight gain triggers specifically for mazdutide. If you are taking mazdutide and noticing unexpected weight gain, the cause is more likely related to a separate factor such as a concurrent medication, a dietary pattern, or an underlying condition rather than to mazdutide itself.

When Weight Gain Can Occur: The Rebound Effect

The scenario where mazdutide users are most likely to experience weight gain is after stopping the medication. This is called rebound weight gain, and it is well-documented across the entire GLP-1 drug class, not just mazdutide.

While mazdutide is active, it suppresses appetite and alters the gut hormone signals that drive hunger. When the drug is discontinued, those signals return to their pre-treatment baseline. Calorie intake tends to rise, often without the person fully recognizing the shift, and body weight follows. Studies on similar agents, including semaglutide, show that patients can regain a substantial portion of their lost weight within 12 months of stopping treatment. Mazdutide, as a member of the same drug class, carries a comparable risk based on its shared mechanism.

This is why stopping mazdutide without a structured plan, whether that means a tapering schedule or a transition to another therapy, is generally discouraged by clinicians.

Factors That May Influence Your Weight While on Mazdutide

Several individual factors can affect how your weight responds during mazdutide treatment, even when the drug is working as intended.

• Dose level. Patients on lower doses tend to lose less weight and may experience smaller protective effects against weight fluctuation.
• Diet quality. Mazdutide is not a standalone solution. Dietary habits during treatment strongly shape outcomes, and calorie-dense foods can partially offset the appetite-suppressing effect.
• Comorbid conditions. Hypothyroidism, insulin resistance, polycystic ovary syndrome, and other metabolic conditions can counteract weight loss independently of what mazdutide is doing.
• Other medications. Corticosteroids, certain antipsychotics, and some antidepressants are known to promote weight gain and can override the effects of a weight loss drug.

If weight is moving in an unexpected direction during treatment, a thorough medication and health history review with a clinician is the appropriate first step.

How Mazdutide Compares to Other Weight Loss Medications

Because mazdutide is newer and not yet widely available outside of clinical research settings, it is helpful to understand how it fits within the broader landscape of weight loss drugs on the question of weight gain risk.

Mazdutide's glucagon receptor activity may offer a metabolic rate advantage over pure GLP-1 drugs by actively increasing energy expenditure rather than relying on appetite reduction alone. This could make weight maintenance slightly more robust during active treatment. However, head-to-head comparisons between mazdutide and semaglutide or tirzepatide on weight rebound specifically remain limited as of early 2025, so drawing firm conclusions is premature.

What to Do If You Notice Unexpected Weight Changes

If you are actively taking mazdutide and noticing weight gain rather than loss, a few steps are worth considering.

First, review any medications you have added recently. Drugs that promote weight gain, including certain steroids, mood stabilizers, and antipsychotics, can work against a GLP-1 agent regardless of dose. Second, consider whether dietary habits have shifted. The appetite suppression mazdutide provides can be partially countered by highly palatable, calorie-dense foods that bypass satiety signals.

Third, ask your clinician whether your current dose is adequate. Some patients require dose adjustments to achieve the intended metabolic effect. And if you are considering stopping mazdutide for any reason, discuss a transition plan with a provider before discontinuing. Stopping abruptly without an alternative strategy significantly raises the risk of rapid rebound weight gain, which can be discouraging and difficult to reverse.

Doctronic offers 24/7 access to free AI consultations and $39 video visits, making it straightforward to get expert-aligned guidance on weight loss medication questions without waiting for a traditional appointment. With over 22 million AI consultations completed, Doctronic provides an accessible starting point for evaluating your next steps.

Frequently Asked Questions

Can mazdutide cause weight gain while you are actively taking it?

Clinical trial data does not identify weight gain as a direct side effect of mazdutide during active treatment. Most participants experienced dose-dependent weight loss. Underlying conditions or other medications may cause weight changes, but those are generally unrelated to mazdutide's direct pharmacological action on appetite and metabolism.

Why do people gain weight after stopping mazdutide?

Mazdutide suppresses appetite and alters gut hormone signaling while active. When the medication is stopped, those signals return to baseline and calorie intake tends to rise. This rebound pattern is well-documented across GLP-1 class drugs and is the primary reason clinicians recommend a structured transition plan before discontinuing.

How much weight can you expect to lose on mazdutide?

Phase 2 and phase 3 clinical trials, conducted primarily in China, showed significant body weight reductions at multiple dose levels. Higher doses generally produced greater losses. Results vary based on diet, activity level, dose, and individual metabolic factors, so a clinician can help set realistic expectations for your specific situation.

Is mazdutide approved in the United States for weight loss?

As of early 2025, mazdutide has not received FDA approval in the United States for obesity or weight management. Most clinical trial data comes from studies conducted in China. Patients in the US interested in GLP-1 based obesity treatments currently have access to other approved options like semaglutide and tirzepatide.

What happens to your weight if you stop mazdutide suddenly?

Stopping mazdutide abruptly without a plan increases the risk of rebound weight gain. Evidence from similar GLP-1 class drugs shows patients can regain a significant portion of lost weight within 12 months of stopping. A clinician can help create a tapering or transition strategy to reduce this risk and protect your progress.

The Bottom Line

Mazdutide does not cause weight gain as a direct side effect during active treatment. Its dual GLP-1 and glucagon receptor mechanism works to reduce appetite and increase energy expenditure, making it a weight loss agent rather than a weight gain trigger. The real concern arises after stopping the medication, when hunger signals return and rebound weight gain becomes possible, a risk shared across the GLP-1 drug class. Planning any change to your mazdutide regimen with a qualified clinician is the most important step you can take to protect your progress. Doctronic offers free AI consultations and $39 video visits, available 24/7, to help you navigate your weight loss medication questions with guidance that achieves 99.2% treatment plan alignment with board-certified physicians. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.